Datasea Advances FDA Compliance for Acoustic BCI Device
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
NEW TAIPEI CITY, Taiwan, June 11, 2026 GlycoNex, Inc. (GNX) announced positive topline results from its Phase III clinical...
NEWPORT BEACH, Calif., June 11, 2026 Wave Neuroscience announced that the U.S. Food and Drug Administration (FDA) has granted...
BOSTON, Mass., May 12, 2026 Tolion Health AI has announced the launch of the latest version of its Tolion...
ROME, Italy and CORAL GABLES, Florida, United States – May 7, 2026 Angelini Pharma S.p.A. and Catalyst Pharmaceuticals Inc....
CHICAGO, IL – November 11, 2025 — Scientists at Northwestern University Feinberg School of Medicine have developed a novel...
